Skip to Main Content

Author Details

Ting Martin Ma
University of Washington
2010
44
15
PMIDPaper TitleJournal TitlePublished Year
37871887Impact of Interfractional Bladder and Trigone Displacement and Deformation on Radiation Exposure and Subsequent Acute Genitourinary Toxicity: A Post Hoc Analysis of Patients Treated with Magnetic Resonance Imaging-Guided Prostate Stereotactic Body Radiation Therapy in a Phase 3 Randomized Trial.Int J Radiat Oncol Biol Phys2024
37661040Stereotactic Body Radiation Therapy: A Radiosurgery Society Guide to the Treatment of Localized Prostate Cancer Illustrated by Challenging Cases.Pract Radiat Oncol2024
36007724Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 Trial.Int J Radiat Oncol Biol Phys2023
37647496Selecting the optimal radiation modality in prostate cancer.Clin Adv Hematol Oncol2023
38039002Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate Cancer.JAMA Netw Open2023
37639648Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.J Clin Oncol2023
37141981High Recurrence for HPV-Positive Oropharyngeal Cancer With Neoadjuvant Radiation Therapy to Gross Disease Plus Immunotherapy: Analysis From a Prospective Phase Ib/II Clinical Trial.Int J Radiat Oncol Biol Phys2023
36966268Race-dependent association of clinical trial participation with improved outcomes for high-risk prostate cancer patients treated in the modern era.Prostate Cancer Prostatic Dis2023
36870853Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission Tomography.Eur Urol Oncol2023
36532603Experience of Telemedicine Visits in Radiation Oncology During the COVID-19 Pandemic: A US National Survey and Lessons Learned for Incorporating Telemedicine Post-COVID-19.Adv Radiat Oncol2023
36797449LUNAR: a randomized Phase 2 study of <sup>177</sup> Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol).BJU Int2023
36633877Magnetic Resonance Imaging-Guided vs Computed Tomography-Guided Stereotactic Body Radiotherapy for Prostate Cancer: The MIRAGE Randomized Clinical Trial.JAMA Oncol2023
36179990External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.Int J Radiat Oncol Biol Phys2023
36106703Fully automated segmentation of prostatic urethra for MR-guided radiation therapy.Med Phys2023
36269935Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials.J Clin Oncol2023
36220855"Targeted microwave ablation: another way to kick the can(cer) down the road?"Prostate Cancer Prostatic Dis2023
34400799Radiation therapy dose and androgen deprivation therapy in localized prostate cancer: a meta-regression of 5-year outcomes in phase III randomized controlled trials.Prostate Cancer Prostatic Dis2022
35469702High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium.Eur Urol2022
37273926Web-Based Symptom Monitoring With Patient-Reported Outcomes During Definitive Radiation Therapy With Chemotherapy (SYMPATHY): A Prospective Single-Center Phase 1 Study.Adv Radiat Oncol2022
35934601Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN).Eur Urol2022
33602654Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging.Eur Urol Oncol2022
35155458The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated With Convalescent Plasma.Front Med (Lausanne)2022
35205686A Prospective Phase II Study of Automated Non-Coplanar VMAT for Recurrent Head and Neck Cancer: Initial Report of Feasibility, Safety, and Patient-Reported Outcomes.Cancers (Basel)2022
35051385Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.Lancet Oncol2022
35050303Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.JAMA Oncol2022
33975579Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial.BMC Cancer2021
33501470The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated with Convalescent Plasma.medRxiv2021
34902034Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.JAMA Netw Open2021
34964855Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis.JAMA Netw Open2021
34671700Time-Driven Activity-Based Costing of CT-Guided vs MR-Guided Prostate SBRT.Appl Radiat Oncol2021
33363041MR-Guided Radiotherapy for Prostate Cancer.Front Oncol2020
33276562Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy.Cancers (Basel)2020
30927606Multi-atlas based detection and localization (MADL) for location-dependent quantification of white matter hyperintensities.Neuroimage Clin2019
30723021Understanding the underutilization of cervical brachytherapy for locally advanced cervical cancer.Brachytherapy2019
31093355Response to R-CHOP in HPV-related squamous cell carcinoma of base of tongue: a case report.Cancers Head Neck2018
27236496The Role of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Active Surveillance.Eur Urol2017
29128167A prospective evaluation of hippocampal radiation dose volume effects and memory deficits following cranial irradiation.Radiother Oncol2017
26245967Inositol Hexakisphosphate Kinase-3 Regulates the Morphology and Synapse Formation of Cerebellar Purkinje Cells via Spectrin/Adducin.J Neurosci2015
24438809Surgical outcomes of craniocervial junction meningiomas: a series of 22 consecutive patients.Clin Neurol Neurosurg2014
25164819Serine racemase regulated by binding to stargazin and PSD-95: potential N-methyl-D-aspartate-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (NMDA-AMPA) glutamate neurotransmission cross-talk.J Biol Chem2014
22801410Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via D-serine depletion.Mol Psychiatry2013
23884950D-serine in glia and neurons derives from 3-phosphoglycerate dehydrogenase.J Neurosci2013
21262972Protein kinase A-mediated 14-3-3 association impedes human Dapper1 to promote dishevelled degradation.J Biol Chem2011
20231879Reverse engineering of bacterial chemotaxis pathway via frequency domain analysis.PLoS One2010
  • 1 - 44 of 44

Recommended Authors

Chenyang Wang
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Career Start Year 2017
Number of shared co-authors 31
Hilary P Bagshaw
Stanford University
Career Start Year 2014
Number of shared co-authors 32
Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 20
Andrew Warner
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 5
Kiri A Sandler
Oregon Health and Science University
Career Start Year 2012
Number of shared co-authors 43
Darlene Veruttipong
Stanford University
Career Start Year 2012
Number of shared co-authors 9
Matthew P Deek
Rutgers Robert Wood Johnson Medical School, Rutgers University
Career Start Year 2011
Number of shared co-authors 30
Xin Pei
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 4
Alan Dal Pra
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 19
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 8
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 6
Bridget F Koontz
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 27
Mitchell Kamrava
Cedars Sinai Medical Center
Career Start Year 2005
Number of shared co-authors 21
Nicholas van As
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Career Start Year 2005
Number of shared co-authors 3
Nima Aghdam
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 32
Ananya Choudhury
University of Manchester and The Christie NHS Foundation Trust
Career Start Year 2004
Number of shared co-authors 15
Neil B Desai
University of Texas Southwestern Medical Center
Career Start Year 2004
Number of shared co-authors 31
Piet Ost
Ghent University, GZA Ziekenhuizen
Career Start Year 2002
Number of shared co-authors 32
Neha Vapiwala
Abramson Cancer Center, University of Pennsylvania
Career Start Year 2001
Number of shared co-authors 43
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 4
Amit Bahl
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 6
Drew Moghanaki
University of California Los Angeles
Career Start Year 2000
Number of shared co-authors 14
Mark K Buyyounouski
Stanford University
Career Start Year 1999
Number of shared co-authors 40
Robert B Den
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 45
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 7
Constantine A Mantz
University of Chicago
Career Start Year 1997
Number of shared co-authors 33
Simeng Suy
MedStar Georgetown University Hospital
Career Start Year 1996
Number of shared co-authors 35
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 7
Christopher R King
University of California los angeles
Career Start Year 1988
Number of shared co-authors 62
Anthony V D'Amico
Duke University Medical Center
Career Start Year 1988
Number of shared co-authors 67

Collaborators

Amar U Kishan
University of California los angeles
Co-authored papers 30
Michael L Steinberg
University of California los angeles
Co-authored papers 20
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 16
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Co-authored papers 15
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 13
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 12
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 11
Tahmineh Romero
David Geffen School of Medicine at university of california los angeles
Co-authored papers 9
Minsong Cao
University of California Los Angeles
Co-authored papers 9
Michael Xiang
University of California los angeles
Co-authored papers 8
Thomas M Pisansky
Mayo Clinic
Co-authored papers 7
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Co-authored papers 7
Xavier Maldonado
Hospital Universitari Vall d'Hebron
Co-authored papers 5
Jesus E Juarez
University of California Los Angeles
Co-authored papers 5
Philippe Maingon
Pitie-Salpetriere Hospital, AP-HP.Sorbonne Universite
Co-authored papers 5
Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
Co-authored papers 5
Araceli Guerrero
Hospital Son Espases
Co-authored papers 5
Luca F Valle
University of California los angeles
Co-authored papers 5
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 5
Michel Bolla
universite Grenoble-Alpes (UGA)
Co-authored papers 5
Paul C Boutros
University of California los angeles
Co-authored papers 5
Almudena Zapatero
University Hospital La Princesa
Co-authored papers 5
Robert T Dess
University of Michigan ann arbor
Co-authored papers 5
David Elashoff
David Geffen School of Medicine at University of California los angeles
Co-authored papers 5
Jeff M Michalski
Washington University School of Medicine
Co-authored papers 4
Wolfgang Lilleby
Oslo University Hospital
Co-authored papers 4
Allison Steigler
University of Newcastle
Co-authored papers 4
David Shabsovich
university of california los angeles Medical Center
Co-authored papers 4
James W Denham
University of Newcastle
Co-authored papers 4
Yingli Yang
Ruijin Hospital
Co-authored papers 4
Release 1.2